PCRX

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

Dollar change +0.06
Percentage change 0.30	%

Peers: INCY EXEL ACAD RDUS ENTA CORT ANAB LGND AMLX PBYI

| Held by: CALF IJR IWM VTI VB VBR VXF IJS SPSM IWN

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.05	Insider Own	3.45%	Shs Outstand	46.15M	Perf Week	3.06%
Market Cap	919.78M	Forward P/E	6.82	EPS next Y	2.91	Insider Trans	0.84%	Shs Float	44.58M	Perf Month	20.73%
Income	-90.73M	PEG	-	EPS next Q	0.79	Inst Own	112.54%	Short Float	10.76%	Perf Quarter	47.22%
Sales	694.96M	P/S	1.32	EPS this Y	10.31%	Inst Trans	-2.61%	Short Ratio	6.13	Perf Half Y	-29.40%
Book/sh	16.24	P/B	1.22	EPS next Y	-6.01%	ROA	-5.94%	Short Interest	4.80M	Perf Year	-33.53%
Cash/sh	9.80	P/C	2.03	EPS next 5Y	10.80%	ROE	-11.48%	52W Range	11.16 - 35.95	Perf YTD	-41.14%
Dividend Est.	-	P/FCF	4.75	EPS past 5Y	-	ROI	-7.67%	52W High	-44.76%	Beta	0.79
Dividend TTM	-	Quick Ratio	1.89	Sales past 5Y	15.46%	Gross Margin	66.11%	52W Low	77.89%	ATR (14)	0.95
Dividend Ex-Date	-	Current Ratio	2.25	EPS Y/Y TTM	-1436.11%	Oper. Margin	14.68%	RSI (14)	64.10	Volatility	5.17% 5.22%
Employees	712	Debt/Eq	0.86	Sales Y/Y TTM	4.40%	Profit Margin	-13.06%	Recom	2.78	Target Price	18.12
Option/Short	Yes / Yes	LT Debt/Eq	0.58	EPS Q/Q	-1462.16%	Payout	0.00%	Rel Volume	0.77	Prev Close	19.80
Sales Surprise	-0.57%	EPS Surprise	12.14%	Sales Q/Q	2.83%	Earnings	Nov 06 AMC	Avg Volume	782.57K	Price	19.86
SMA20	10.32%	SMA50	14.98%	SMA200	-9.53%	Trades		Volume	605,475	Change	0.30%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-13-24	Downgrade	Truist	Buy → Sell	$30 → $8
Aug-12-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$37 → $14
Aug-12-24	Downgrade	Raymond James	Outperform → Mkt Perform
Aug-12-24	Downgrade	Piper Sandler	Overweight → Neutral	$42 → $11
Aug-12-24	Downgrade	JP Morgan	Overweight → Underweight	$45 → $10
Jul-03-24	Downgrade	Barclays	Overweight → Equal Weight	$38 → $25
Mar-07-24	Resumed	JP Morgan	Overweight	$80 → $45
Dec-20-23	Initiated	Raymond James	Outperform	$42
Aug-03-23	Upgrade	TD Cowen	Market Perform → Outperform	$50
Jan-31-23	Resumed	Wedbush	Outperform	$88 → $60
Oct-21-22	Resumed	Jefferies	Buy	$66
Jan-03-22	Resumed	JP Morgan	Overweight	$75 → $83
Jul-26-21	Upgrade	JP Morgan	Neutral → Overweight	$75
Apr-21-21	Resumed	JP Morgan	Neutral	$70
Apr-09-21	Initiated	Berenberg	Buy	$93
Apr-07-21	Resumed	RBC Capital Mkts	Outperform	$86
Feb-11-21	Downgrade	Northland Capital	Outperform → Market Perform	$72 → $75
Jan-21-21	Downgrade	SVB Leerink	Outperform → Mkt Perform	$75
Sep-21-20	Upgrade	Northland Capital	Market Perform → Outperform	$58 → $67
Jul-06-20	Reiterated	Needham	Buy	$52 → $64

Show Previous Ratings

Dec-11-24 08:05AM	DOMA Perpetual Capital Management Announces Intent to Nominate Four Highly Qualified, Independent Director Candidates at 2025 Annual Meeting of Pacira BioSciences, Inc. (PR Newswire)
Dec-06-24 08:00AM	Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (GlobeNewswire)
Dec-03-24 07:30AM	Pacira Awarded New U.S. Patent Covering EXPAREL Composition (GlobeNewswire) -6.34%
Nov-29-24 09:50AM	Why Pacira (PCRX) is a Top Momentum Stock for the Long-Term (Zacks)
Nov-14-24 10:05AM	Pacira Announces 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee (GlobeNewswire)
08:00AM	Loading…
Nov-12-24 08:00AM	Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences (GlobeNewswire)
Nov-07-24 08:49AM	Q3 2024 Pacira Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
02:20AM	Pacira BioSciences Inc (PCRX) Q3 2024 Earnings Call Highlights: Strong Financial Position ... (GuruFocus.com)
Nov-06-24 04:10PM	Pacira: Q3 Earnings Snapshot (Associated Press Finance)
04:00PM	Pacira BioSciences Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-05-24 07:55AM	Pacira BioSciences Inc (PCRX) Q3 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com) +5.05%
Nov-04-24 08:00AM	Centers for Medicare and Medicaid Services (CMS) Establishes Additional Payment for iovera in Outpatient Settings (GlobeNewswire)
Oct-30-24 08:00AM	Pacira to Report Third Quarter 2024 Financial Results on Wednesday November 6, 2024 (GlobeNewswire)
Oct-21-24 08:38AM	Are Options Traders Betting on a Big Move in Pacira BioSciences (PCRX) Stock? (Zacks)
08:00AM	Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer (GlobeNewswire)
08:00AM	Loading…
Oct-07-24 08:00AM	Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (GlobeNewswire)
Oct-03-24 08:00AM	Pacira BioSciences Announces New Product-Specific J-Code for EXPAREL Effective January 1, 2025 (GlobeNewswire)
Sep-26-24 08:00AM	Pacira Announces the Presentation of 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee (GlobeNewswire)
Sep-25-24 08:15AM	DOMA Perpetual Sends Letter to Board of Directors of Pacira Biosciences to Immediately Accelerate and Increase its Share Buyback Program to Enhance Return to Shareholders (PR Newswire)
Sep-09-24 04:00PM	Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (GlobeNewswire)
Aug-09-24 03:21PM	Pacira BioSciences Comments on Ruling on EXPAREL Patent Litigation from U.S. District Court for the District of New Jersey (GlobeNewswire) -47.67%
Jul-31-24 10:49AM	Pacira (PCRX) Q2 Earnings Beat, Exparel Sales Drive Revenues (Zacks) +5.68%
Jul-30-24 08:58PM	PCRX Stock Earnings: Pacira BioSciences Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace)
04:14PM	Pacira: Q2 Earnings Snapshot (Associated Press Finance)
04:00PM	Pacira BioSciences Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-29-24 06:00AM	3 Biotech Stocks to Buy on the Dip: July 2024 (InvestorPlace)
Jul-23-24 08:00AM	Pacira to Report Second Quarter 2024 Financial Results on Tuesday July 30, 2024 (GlobeNewswire)
03:52AM	Nanotechnology in medicine: Who are the leading public companies? (Medical Device Network)
Jul-17-24 09:50AM	Should Value Investors Buy Pacira BioSciences (PCRX) Stock? (Zacks)
Jul-12-24 10:41AM	Pacira (PCRX) Rises on Proposed Exparel Reimbursement Plan (Zacks)
04:19PM	Loading…
Jul-10-24 04:19PM	Centers for Medicare and Medicaid Propose New Reimbursement for EXPAREL in All Outpatient Surgical Environments Beginning January 1, 2025 (GlobeNewswire) +7.23%
Jun-14-24 02:41AM	Insider Sale: Chief Medical Officer Jonathan Slonin Sells Shares of Pacira BioSciences Inc (PCRX) (GuruFocus.com)
Jun-06-24 11:31AM	Why Is Pacira (PCRX) Up 1.7% Since Last Earnings Report? (Zacks)
May-30-24 08:00AM	Pacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare Conference (GlobeNewswire)
May-10-24 07:00AM	Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029 (GlobeNewswire)
May-08-24 04:05PM	Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior Notes (GlobeNewswire) +11.84%
11:35AM	Pacira (PCRX) Q1 Earnings Miss, Exparel Sales Drive Revenues (Zacks)
09:33AM	Pacira BioSciences, Inc. (NASDAQ:PCRX) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:47AM	Pacira BioSciences Inc (PCRX) (Q1 2024) Earnings Call Transcript Highlights: Strategic Growth ... (GuruFocus.com)
May-07-24 09:01PM	PCRX Stock Earnings: Pacira BioSciences Meets EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:03PM	Pacira BioSciences Reports Q1 2024 Results: Aligns with EPS Projections and Announces $150 ... (GuruFocus.com)
05:30PM	Here's What Key Metrics Tell Us About Pacira (PCRX) Q1 Earnings (Zacks)
04:13PM	Pacira: Q1 Earnings Snapshot (Associated Press Finance)
04:00PM	Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Repurchase program (GlobeNewswire)
08:00AM	Pacira BioSciences to Participate in Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
Apr-30-24 08:00AM	Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024 (GlobeNewswire)
Apr-04-24 11:33AM	Aggressive Stock Portfolio: 13 Stocks Picked by Analysts (Insider Monkey)
Apr-02-24 08:00AM	Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-14-24 08:23AM	Pacira's (PCRX) Knee Osteoarthritis Drug Gets FDA's RMAT Tag (Zacks)
Mar-13-24 07:00AM	Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Knee (GlobeNewswire)
Mar-08-24 11:55PM	Director Gary Pace Sells 119,323 Shares of Pacira BioSciences Inc (PCRX) (GuruFocus.com)
Mar-06-24 08:00AM	Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Conference (GlobeNewswire)
Mar-04-24 08:28PM	11 Best Small Cap Pharma Stocks to Invest In (Insider Monkey)
Mar-01-24 08:38AM	Pacira BioSciences, Inc. (NASDAQ:PCRX) Q4 2023 Earnings Call Transcript (Insider Monkey)
06:05AM	Pacira (PCRX) Q4 Earnings Match, Exparel Sales Drive Revenues (Zacks)
12:28AM	Q4 2023 Pacira Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-29-24 10:00AM	Here's What Key Metrics Tell Us About Pacira (PCRX) Q4 Earnings (Zacks)
09:15AM	Pacira (PCRX) Matches Q4 Earnings Estimates (Zacks)
08:32AM	Pacira BioSciences Inc (PCRX) Reports Record Revenues and Robust Earnings for Full-Year 2023 (GuruFocus.com)
08:26AM	Pacira: Q4 Earnings Snapshot (Associated Press Finance)
08:00AM	Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results (GlobeNewswire)
Feb-22-24 08:00AM	Pacira to Report 2023 Financial Results on Thursday February 29, 2024 (GlobeNewswire)
Feb-15-24 08:36AM	Pacira Announces Publication of Pivotal Study of EXPAREL as a Sciatic Nerve Block in the Popliteal Fossa for Patients After Bunionectomy (GlobeNewswire)
Feb-07-24 08:00AM	Pacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc. (GlobeNewswire) -7.44%
Feb-01-24 10:45AM	G.O.A.T. Bowl I Registration Open to 4 Additional Pickleball Teams (PR Newswire)
Jan-05-24 12:21PM	Pacira (PCRX) Preliminary '23 Revenues Solid, Exparel Strong (Zacks) +5.71%
Jan-04-24 05:00PM	Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues (GlobeNewswire)
Jan-03-24 08:00AM	Pacira BioSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-21-23 07:30AM	Pacira Appoints Frank D. Lee as Chief Executive Officer (GlobeNewswire)
Dec-06-23 11:13AM	Hedge Funds are Betting on These 14 Sliding Stocks (Insider Monkey)
Nov-13-23 10:10AM	Pacira (PCRX) Gets FDA Nod for Exparel's Label Expansion (Zacks)
Nov-10-23 07:30AM	Pacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block Indications (GlobeNewswire)
Nov-07-23 08:00AM	Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in November (GlobeNewswire)
Nov-04-23 10:28AM	Pacira BioSciences, Inc. (NASDAQ:PCRX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-02-23 12:34PM	Pacira (PCRX) Q3 Earnings and Revenues Miss, '23 View Updated (Zacks)
10:00AM	Pacira BioSciences Inc (PCRX) Reports Q3 2023 Financial Results (GuruFocus.com)
08:23AM	Pacira: Q3 Earnings Snapshot (Associated Press Finance)
08:00AM	Pacira BioSciences Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-26-23 08:00AM	Pacira to Report Third Quarter 2023 Financial Results on Thursday November 2, 2023 (GlobeNewswire)
Oct-12-23 08:00AM	American Society of Anesthesiologists Announces New Industry Supporter Pacira BioSciences, Inc. (GlobeNewswire)
Oct-10-23 08:00AM	Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors (GlobeNewswire)
Oct-02-23 08:00AM	American Society of Anesthesiologists and Pacira BioSciences, Inc. Announce New Grant to Advance Education and Enhance Patient Care (GlobeNewswire)
Sep-27-23 12:07PM	Unraveling the Future of Pacira BioSciences Inc (PCRX): A Deep Dive into Key Metrics (GuruFocus.com) -6.51%
11:50AM	Unveiling Pacira BioSciences (PCRX)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com)
Sep-26-23 04:30PM	Pacira BioSciences Announces Leadership Succession Plan (GlobeNewswire)
Sep-06-23 08:00AM	Pacira BioSciences Announces Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Aug-03-23 10:03AM	Qualcomm downgraded, Wingstop upgraded: Wall Street's top analyst calls (The Fly) +5.56%
Aug-02-23 12:45PM	Pacira (PCRX) Q2 Earnings and Sales Miss, '23 View Updated (Zacks)
08:11AM	Pacira: Q2 Earnings Snapshot (AP Finance)
08:00AM	Pacira BioSciences Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-28-23 02:56PM	10 Best Small Cap Pharma Stocks to Buy (Insider Monkey)
Jul-26-23 08:00AM	Pacira to Report Second Quarter 2023 Financial Results on Wednesday August 2, 2023 (GlobeNewswire)
Jun-21-23 08:00PM	PCRX: Raising target price to $42.00 (Argus Research)
Jun-02-23 11:31AM	Why Is Pacira (PCRX) Down 11.8% Since Last Earnings Report? (Zacks)
May-31-23 08:00AM	Pacira BioSciences to Participate in Fireside Chat at the 2023 Jefferies Healthcare Conference (GlobeNewswire)
May-09-23 08:00AM	Pacira BioSciences to Participate in Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
May-03-23 11:42PM	Q1 2023 Pacira Biosciences Inc Earnings Call (Thomson Reuters StreetEvents) -7.17%
05:25PM	Why Pacira BioSciences Shares Are Trading Lower Today (Benzinga)
03:11PM	Pacira (PCRX) Q1 Earnings Miss Estimates, Revenues Beat (Zacks)
08:11AM	Pacira: Q1 Earnings Snapshot (AP Finance)

Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients' journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GAUGLER DARYL	Officer	Dec 13 '24	Proposed Sale	19.76	500	9,880		Dec 13 09:41 AM
GAUGLER DARYL	Chief Operating Officer	Sep 13 '24	Sale	12.86	500	6,430	115,700	Sep 13 08:29 PM
GAUGLER DARYL	Officer	Sep 13 '24	Proposed Sale	12.86	500	6,430		Sep 13 10:17 AM
BIGAL MARCELO	Director	Aug 16 '24	Buy	13.25	1,512	20,034	10,142	Aug 19 08:25 AM
Brege Laura	Director	Aug 16 '24	Buy	12.81	1,000	12,810	17,552	Aug 19 08:25 AM
YANG MICHAEL J.	Director	Aug 14 '24	Buy	12.90	2,000	25,800	7,230	Aug 14 04:35 PM
Lee Frank D.	Chief Executive Officer	Aug 12 '24	Buy	12.10	8,264	99,994	107,784	Aug 13 04:55 PM
Froimson Mark	Director	Aug 12 '24	Buy	11.58	1,400	16,212	14,473	Aug 12 08:33 PM
BIGAL MARCELO	Director	Aug 12 '24	Buy	12.01	3,400	40,834	8,630	Aug 12 08:33 PM
SLONIN JONATHAN	Chief Medical Officer	Aug 02 '24	Sale	20.05	945	18,947	94,307	Aug 02 06:00 PM
SLONIN JONATHAN	Officer	Aug 02 '24	Proposed Sale	20.05	945	18,947		Aug 02 10:09 AM
SLONIN JONATHAN	Chief Medical Officer	Jul 02 '24	Sale	28.25	2,836	80,117	95,557	Jul 03 06:52 PM
RIKER LAUREN	Senior Vice President, Finance	Jun 12 '24	Sale	28.72	3,970	114,018	38,075	Jun 13 06:15 PM
SLONIN JONATHAN	Chief Medical Officer	Jun 11 '24	Sale	28.57	5,012	143,193	44,569	Jun 13 06:15 PM
GAUGLER DARYL	Chief Operating Officer	Jun 13 '24	Sale	28.38	1,000	28,380	116,040	Jun 13 06:13 PM
HASTINGS PAUL J	Director	Jun 13 '24	Sale	28.38	880	24,974	12,724	Jun 13 06:13 PM
WILLIAMS KRISTEN	Chief Administrative Officer	Jun 13 '24	Sale	28.38	7,452	211,488	102,912	Jun 13 06:12 PM
PACE GARY W	Director	Mar 08 '24	Sale	30.60	90,000	2,754,000	22,127	Mar 08 05:33 PM
PACE GARY W	Director	Mar 07 '24	Sale	30.81	28,257	870,598	112,127	Mar 08 05:33 PM
PACE GARY W	Director	Mar 06 '24	Sale	29.67	1,066	31,628	140,384	Mar 08 05:33 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Pacira BioSciences Inc

Upgrade your FINVIZ experience